White R H, Zhou H, Romano P, Mungall D
University of California, Davis, USA.
Clin Pharmacol Ther. 1995 Nov;58(5):588-93. doi: 10.1016/0009-9236(95)90179-5.
To determine the relative contribution of changes in the plasma warfarin level to variation in the serial steady-state prothrombin times.
This was a prospective observational cohort study performed at two outpatient anticoagulation clinics. Serial prothrombin times and paired plasma total warfarin levels were determined in a convenience sample of otherwise healthy patients who required long-term oral anticoagulation therapy with warfarin.
Serial measurements were obtained from 129 patients, 60 of whom provided three or more serial samples. Analysis of covariance showed a highly significant (p = 0.0001) relationship between the anticoagulant effect and the logarithm of the warfarin concentration (R2 = 0.75), with 15.3% of the total variance attributable to the effect of warfarin and 31.1% attributable to individual variation in sensitivity to warfarin. In an analysis of the subjects who had three or more serial measurements, the mean weighted correlation coefficient for the relationship between the logarithm of the warfarin concentration and the anticoagulant response varied widely, from strongly negative to strongly positive, and as the range of observed prothrombin times increased, stronger positive correlation was observed.
In this cohort, the plasma warfarin level was a strong predictor of observed changes in serial prothrombin time measurements. However, the correlation between clotting times and warfarin levels varied widely among subjects, particularly when the range of observed prothrombin times was moderate. This suggests that in these subjects, other factors, such as measurement error or pharmacodynamic changes, played a major role.
确定血浆华法林水平变化对系列稳态凝血酶原时间变异的相对贡献。
这是一项在两家门诊抗凝诊所进行的前瞻性观察队列研究。对需要长期口服华法林进行抗凝治疗的健康患者的便利样本,测定其系列凝血酶原时间和配对的血浆总华法林水平。
从129例患者中获得了系列测量值,其中60例提供了三个或更多的系列样本。协方差分析显示抗凝效果与华法林浓度的对数之间存在高度显著的关系(p = 0.0001)(R2 = 0.75),总变异的15.3%归因于华法林的作用,31.1%归因于对华法林敏感性的个体差异。在对有三个或更多系列测量值的受试者进行的分析中,华法林浓度对数与抗凝反应之间关系的平均加权相关系数变化很大,从强负相关到强正相关,并且随着观察到的凝血酶原时间范围增加,观察到更强的正相关。
在该队列中,血浆华法林水平是观察到的系列凝血酶原时间测量变化的有力预测指标。然而,凝血时间与华法林水平之间的相关性在受试者之间差异很大,特别是当观察到的凝血酶原时间范围适中时。这表明在这些受试者中,其他因素,如测量误差或药效学变化,起了主要作用。